Our goal is to develop therapeutics that will dramatically improve the standard-of-care for those with cancer.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $379.7M
Founded date: 2016
Investors 7
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.12.2020 | Series C | $131.2M | - |
| 06.06.2020 | Series B | $98.5M | - |
| 03.10.2017 | Series A | $150M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 18.12.2020 | Cullinan Oncology Completes $131.2 Million Series C Financin... | - | mpmcapital... |
| 17.12.2020 | Cullinan Oncology, Inc. announced that it has received $131.... | Cullinan Oncology, LLC announced that it has issued 66,599,045 series C preferred stock at a price o... | marketscre... |
| 17.12.2020 | Cullinan Oncology Completes $131.2 Million Series C Financin... | - | orbimed.co... |
| 17.12.2020 | Cullinan Oncology Closes $131.2 Million Series C Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cullinan Oncology, LLC, a biopharmaceutical company focused on de... | citybizlis... |
| 11.06.2020 | Fueled with a fresh cash injection, Cullinan expands i... | Fresh off of a $98.5 million raise, Patrick Baeuerle’s team at Cullinan Oncology has a new su... | endpts.com... |
| 06.06.2020 | Cullinan Oncology Completes $98.5 Million Series B Financing | - | mpmcapital... |
| 04.06.2020 | Cullinan Oncology Raises $98.5M Series B | CAMBRIDGE, MA, Cullinan Oncology announced today the closing of a $98.5 million Series B financing... | vcnewsdail... |
| 04.06.2020 | Cullinan Oncology Completes $98.5 Million Series B Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cullinan Oncology, LLC announced today the closing of a $98.5 mil... | citybizlis... |
| 04.06.2020 | Cullinan Oncology Closes $98.5M Series B Financing Round | Cullinan Oncology, a Cambridge, Mass.-based oncology research company, closed a $98.5m Series B fina... | finsmes.co... |
| 03.10.2017 | The UBS Oncology Impact Fund Co-leads $150 Million Series A ... | - | mpmcapital... |
Show more